featured
PHI Is Superior to PSA for Predicting Prostate Cancer in Obese Men
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BJU International
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Performance of the Prostate Health Index (PHI) for the Prediction of Prostate Cancer in Obese Men: Data From the PROMEtheuS Project, a Multicentre European Prospective Study
BJU Int 2015 Apr 01;115(4)537-545, A Abrate, M Lazzeri, G Lughezzani, N Buffi, V Bini, A Haese, A de la Taille, T McNicholas, JP Redorta, GM Gadda, G Lista, E Kinzikeeva, N Fossati, A Larcher, P Dell'Oglio, F Mistretta, M Freschi, G GuazzoniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.